De Mangia A et al. Global real world evidence of sofosbuvir/verplatasvir as a simple effective regimen for the treatment of chronic hepatitis C patients: Integrated analysis of 12 clinical practice cohorts. (Abstract GS-03)
“Het voornaamste doel bij post-COVID is symptoomverlichting, vaak niet-medicamenteus”
jun 2026 | Virale infecties